BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919
65 results:

  • 1. Effect of aza-BODIPY-photodynamic therapy on the expression of carcinoma-associated genes and cell death mode.
    Elgun T; Yurttas AG; Cinar K; Ozcelik S; Gul A
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103849. PubMed ID: 37863378
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Zhang L; Ji Q; Chen Q; Wei Z; Liu S; Zhang L; Zhang Y; Li Z; Liu H; Sui H
    Int J Biol Sci; 2023; 19(14):4393-4410. PubMed ID: 37781044
    [No Abstract]    [Full Text] [Related]  

  • 3. FOXO1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells.
    Pintor S; Lopez A; Flores D; Lozoya B; Soti B; Pokhrel R; Negrete J; Persans MW; Gilkerson R; Gunn B; Keniry M
    FEBS Open Bio; 2023 Nov; 13(11):2108-2123. PubMed ID: 37584250
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
    Hu Y; Fan S; Zhu Y; Xie X
    Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Peripheral blood mononuclear cell derived biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of breast cancer.
    Kumar S; Das A
    Comput Biol Chem; 2023 Jun; 104():107867. PubMed ID: 37030103
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. WNT3a Signaling Inhibits Aromatase Expression in breast Adipose Fibroblasts-A Possible Mechanism Supporting the Loss of Estrogen Responsiveness of Triple-Negative breast cancers.
    Kaiser A; Eiselt G; Bechler J; Huber O; Schmidt M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902090
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased Expression of lef1 and β-Catenin in Invasive Micropapillary Carcinoma of the breast is Associated With Lymphovascular Invasion and Lymph Node Metastasis.
    Dolezal D; Zhang X; Harigopal M
    Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):557-565. PubMed ID: 35960138
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients.
    Yu H; Lv W; Tan Y; He X; Wu Y; Wu M; Zhang Q
    J Transl Med; 2022 Jul; 20(1):328. PubMed ID: 35864548
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
    Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
    J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. mRNA coexpression patterns of Wnt pathway components and their clinicopathological associations in breast and colorectal cancer.
    Zougros A; Michelli M; Chatziandreou I; Nonni A; Gakiopoulou H; Michalopoulos NV; Lazaris AC; Saetta AA
    Pathol Res Pract; 2021 Nov; 227():153649. PubMed ID: 34656913
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
    Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
    Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
    Chen PH; Bossuyt V; Reisenbichler E
    Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
    Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
    Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Concurrent Wnt pathway component expression in breast and colorectal cancer.
    Michelli M; Zougros A; Chatziandreou I; Michalopoulos NV; Lazaris AC; Saetta AA
    Pathol Res Pract; 2020 Jul; 216(7):153005. PubMed ID: 32534708
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The expression of KI-67 and LEF-1 in patients after breast cancer resection and its effects on patients' prognosis.
    Chen C; Lu X
    J BUON; 2020; 25(2):627-633. PubMed ID: 32521845
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Quercetin Inhibits lef1 and Resensitizes Docetaxel-Resistant breast cancer Cells.
    Prieto-Vila M; Shimomura I; Kogure A; Usuba W; Takahashi RU; Ochiya T; Yamamoto Y
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32492961
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway.
    Tang C; Gong L; Lvzi Xu ; Qiu K; Zhang Z; Wan L
    Biochem Biophys Res Commun; 2020 May; 526(1):170-175. PubMed ID: 32201078
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. lef1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.
    Blazquez R; Rietkötter E; Wenske B; Wlochowitz D; Sparrer D; Vollmer E; Müller G; Seegerer J; Sun X; Dettmer K; Barrantes-Freer A; Stange L; Utpatel K; Bleckmann A; Treiber H; Bohnenberger H; Lenz C; Schulz M; Reimelt C; Hackl C; Grade M; Büyüktas D; Siam L; Balkenhol M; Stadelmann C; Kube D; Krahn MP; Proescholdt MA; Riemenschneider MJ; Evert M; Oefner PJ; Klein CA; Hanisch UK; Binder C; Pukrop T
    Int J Cancer; 2020 Jun; 146(11):3170-3183. PubMed ID: 31626715
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Single-Cell Analysis Reveals a Preexisting Drug-Resistant Subpopulation in the Luminal breast cancer Subtype.
    Prieto-Vila M; Usuba W; Takahashi RU; Shimomura I; Sasaki H; Ochiya T; Yamamoto Y
    Cancer Res; 2019 Sep; 79(17):4412-4425. PubMed ID: 31289135
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
    Shen H; Yan W; Yuan J; Wang Z; Wang C
    J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.